{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:42:53Z","timestamp":1787877773284,"version":"build-2784847793"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hypertension remains a major contributor to cardiovascular and renal complications in patients with diabetes mellitus, increasing the risk of macrovascular and microvascular disease. The 2025 AHA\/ACC hypertension guidelines maintain a diagnostic and treatment threshold of 130\/80 mmHg, emphasizing earlier and more intensive blood pressure control to reduce cardiovascular events, stroke, heart failure, and progression of diabetic nephropathy. Evidence from clinical trials and meta-analyses supports the benefits of tighter blood pressure targets, while acknowledging potential risks such as hypotension, electrolyte disturbances, and acute kidney injury. Management strategies combine pharmacologic therapy with lifestyle interventions including dietary modification, physical activity, weight management, and smoking cessation. Individualized blood pressure targets are recommended for older or frail patients to balance safety and benefit. Home and ambulatory blood pressure monitoring are highlighted for detecting masked or nocturnal hypertension, enhancing risk stratification, and supporting treatment titration. The guidelines also emphasize integrated risk assessment and multidisciplinary management. The 2025 AHA\/ACC hypertension guidelines provide an evidence-based, patient-centered framework to optimize cardiovascular and renal outcomes in patients with diabetes, promoting early intervention, individualized therapy, and comprehensive risk reduction.<\/jats:p>","DOI":"10.1186\/s40842-025-00239-3","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:36:30Z","timestamp":1756200990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The 2025 AHA\/ACC hypertension guidelines: implications for cardiovascular and renal risk in patients with diabetes"],"prefix":"10.1186","volume":"11","author":[{"given":"Gaetano","family":"Santulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"10497","key":"239_CR1","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/S0140-6736(25)01067-0","volume":"405","author":"S Misra","year":"2025","unstructured":"Misra S, Khunti K, Goyal A, Gable D, Armocida B, Tandon N, Sachdev P, Wild SH, Hivert MF, Beran D. Managing early-onset type 2 diabetes in the individual and at the population level. Lancet. 2025;405(10497):2341\u201354.","journal-title":"Lancet"},{"issue":"4","key":"239_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dci23-0041","volume":"47","author":"N Sattar","year":"2024","unstructured":"Sattar N, Presslie C, Rutter MK, McGuire DK. Cardiovascular and kidney risks in individuals with type 2 diabetes: contemporary Understanding with greater emphasis on excess adiposity. Diabetes Care. 2024;47(4):531\u201343.","journal-title":"Diabetes Care"},{"key":"239_CR3","doi-asserted-by":"crossref","unstructured":"Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, Altieri MM, Bansal N, Bello NA, Bress AP et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension 2025.","DOI":"10.1161\/HYP.0000000000000249"},{"key":"239_CR4","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018, 71(6):1269\u20131324.","DOI":"10.1161\/HYP.0000000000000066"},{"issue":"7","key":"239_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/HYPERTENSIONAHA.124.23087","volume":"81","author":"G Santulli","year":"2024","unstructured":"Santulli G, Visco V, Varzideh F, Guerra G, Kansakar U, Gasperi M, Marro A, Wilson S, Ferrante MNV, Pansini A, et al. Prediabetes increases the risk of frailty in prefrail older adults with hypertension: beneficial effects of Metformin. Hypertension. 2024;81(7):1637\u201343.","journal-title":"Hypertension"},{"issue":"11","key":"239_CR6","doi-asserted-by":"publisher","first-page":"101352","DOI":"10.1016\/j.jacadv.2024.101352","volume":"3","author":"T Fujiwara","year":"2024","unstructured":"Fujiwara T, Hoshide S, Sheppard JP, McManus RJ, Kario K. Cardiovascular events risk in Office-Masked nocturnal hypertension defined by home blood pressure monitoring. JACC Adv. 2024;3(11):101352.","journal-title":"JACC Adv"},{"issue":"38","key":"239_CR7","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"4","key":"239_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40119-024-00381-6","volume":"13","author":"M Sobhy","year":"2024","unstructured":"Sobhy M, Eletriby A, Ragy H, Kandil H, Saleh MA, Farag N, Guindy R, Bendary A, Nayel AME, Shawky A, et al. ACE inhibitors and angiotensin receptor blockers for the primary and secondary prevention of cardiovascular outcomes: recommendations from the 2024 Egyptian cardiology expert consensus in collaboration with the CVREP foundation. Cardiol Ther. 2024;13(4):707\u201336.","journal-title":"Cardiol Ther"},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"111926","DOI":"10.1016\/j.diabres.2024.111926","volume":"218","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Pacella D, Virginia Manzi M, Trama U, Lembo M, Piccinocchi R, Gallo P, Esposito G, Morisco C, et al. Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study. Diabetes Res Clin Pract. 2024;218:111926.","journal-title":"Diabetes Res Clin Pract"},{"key":"239_CR10","doi-asserted-by":"crossref","unstructured":"Rangaswami J, Shlipak MG, Mathew RO, Ndumele CE. The Cardiovascular-Kidney-Metabolic health framework: implications for nephrology. Clin J Am Soc Nephrol 2025. In press.","DOI":"10.2215\/CJN.0000000744"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-025-00239-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:16:24Z","timestamp":1757484984000},"score":1,"resource":{"primary":{"URL":"https:\/\/clindiabetesendo.biomedcentral.com\/articles\/10.1186\/s40842-025-00239-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1186\/s40842-025-00239-3","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"26 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Prof. Santulli is the Editor-in-Chief of Cardiovascular Diabetology - Endocrinology Reports.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"21"}}